By Lauren VanDenBoom
Share

December 10, 2021

Trend 1: COVID-19 will continue to be a concern.

“We now know that we will be co-existing with COVID-19 in some way for the foreseeable future, with no hard stop in sight,” Rick Pollack, President and CEO of the American Hospital Association (AMA), writes in the AMA’s 2022 Environmental Scan. “This will continue to affect not only our nation’s health, but also the ability of hospitals and health systems to improve it… let alone transform it.”

As one would likely expect, COVID-19 is a consistent theme throughout healthcare trends we see for 2022 both for its impact on the industry over the past two years and its continued impact. 

Trend 2: The healthcare industry will look to innovative technology solutions to help ensure healthcare equity. 

According to the Robert Wood Johnson Foundation, “health equity means that everyone has a fair and just opportunity to be as healthy as possible. This requires removing obstacles to health such as poverty, discrimination, and their consequences, including powerlessness and lack of access to good jobs with fair pay, quality education and housing, safe environments, and health care.”

The COVID-19 pandemic brought to light stark differences in access to care based on a multitude of factors. Karen Kobelski, Vice President and General Manager of Clinical Surveillance Compliance & Data Solutions, Wolters Kluwer, Health, told Hospital and Healthcare Management that “the COVID-19 pandemic put a spotlight on health disparities in the U.S. and the industry can no longer turn a blind eye. 2022 will be a pivotal year for making healthcare data help and not hinder the bigger goal of delivering the best care everywhere.” 

According to Forrester Predictions 2022, “health disparities will harm rural Americans at twice the rate of urban Americans. Fifty-seven million people in rural and tribal communities will face increased mortality as a result of social inequalities, multiple chronic health conditions, high suicide rates, dire physician shortages, and sweeping hospital closures.” 

Wolters Kluwer says one source for increased equity will be mining the insights that can be found in unstructured healthcare data. “The critical success factor will be unlocking the 80% of healthcare data that is in unstructured form and making it widely accessible and actionable for stakeholders across care settings,” said Kobelski. “This will be key to making it more actionable for stakeholders across care settings and it is crucial to gaining big-picture insights into our healthcare disparity problem. Machine learning tools such as natural language processing and text mining can help health systems reveal valuable health equity insights hidden in unstructured clinical data that is difficult to store, search, analyze, and share across health systems.”

Trend 3: Data from wearables will begin to play a bigger role in patient care. 

Popular wearable devices like watches and fitness trackers have brought increased health awareness to users, consumers and patients and are generating an immense amount of data that can be used to inform patient care. “General practitioners can take advantage of the widely popular commercial wearable devices like Apple Watch and Fitbit to encourage patients to engage full-time with their health,” writes Lisa Hedges in Software Advice.  

According to the Centers for Disease Control and Prevention (CDC), “if implemented based on science, mobile health technology can greatly empower people to be engaged participants in their care and more responsible for their own health while improving preventive medicine, ultimately saving lives.”  

T.J. Elbert, Senior Vice President and General Manager, Data, at Health Catalyst says Healthcare C-suites will go beyond transactional predictive models and adopt augmented intelligence to support organizational, data-driven decision-making. He told Healthcare IT News that “there will be a need for a data strategy that incorporates new Internet of Things (IoT), patient-portal and wearables data, and the governance and orchestration required to incorporate this data into patient care.” 

Trend 4: Health care systems face the challenge of managing even more data.  

While having more data points on which to base decisions fuels more precise patient care, managing and making sense of all of those data points and turning them into insights providers can easily use is a challenge for healthcare organizations. A critical step in an organization’s journey to deliver precision health is to remove data silos and organize lab data in such a way that actionable insights can be derived and then clearly communicated. All the data is almost useless without a method to ingest, organize, and normalize it into actionable information that is meaningful for providers and patients. 

“The right tools can streamline the creation of actionable, data-informed insights, but doing so under fast-changing circumstances is a bigger challenge,” writes Amy Burroughs in HealthTech.  “However, that’s what providers and researchers are moving toward as they take advantage of both technology and partnerships. In the process, they’re working to improve care and increase equity.” 

According to Elbert, “Healthcare data in 2022 will require greater emphasis on data operations as organizations must curate and manage data as an asset and create a reusable data product. To prepare for this shift now, healthcare leaders must evaluate their data operations capabilities and ask themselves three key questions: What is our data tech strategy to make this transition? What does our data mesh look like? What people and processes do we need in place?”

Trend 5: Concerns over clinician burnout will continue. 

Burnout across the care team was a known issue for healthcare organizations long before COVID-19, however the global pandemic has certainly worsened the problem. “In 2022, a surge of workforce shortages will sweep across the healthcare industry,” according to Forrester Predictions for 2022. The Medscape 2021 Physician Burnout & Suicide Report shows that 42% of physicians reported they were burned out, with 21% of them reporting that their burnout symptoms began after the start of the COVID-19 pandemic. 

Amit Phadnis, Chief Digital Officer at GE Healthcare, said that “Clinicians are just seeing so much data; there’s a risk they’ll be completely fatigued just a few hours into their workday.” 

Innovative ways to condense data into easy-to-use insights are emerging to help with this source of burnout. “Technologists and data scientists will continue to improve the ability of algorithms to gather and analyze those avalanches of data, and then generate a wealth of valuable clinical insights,” Phadnis said. “That has the potential to increase the quality of healthcare, and allow for the fairer distribution of work and decrease the risk of burnout.” 

Trend 6: Patients will  have more options for care at home.

Although the technology and practice of telemedicine has been available for several years, virtual healthcare visits became commonplace during the COVID-19 pandemic. Now that patients and providers are more comfortable with the technology, many believe this shift toward at-home care whenever possible will be permanent. 

“Telemedicine will prove resilient well past the pandemic and will establish itself as a permanent, significant fixture in the healthcare ecosystem,” Vikram Savkar, Vice President & General Manager, Medicine Segment of Health Learning, Research & Practice told Hospital and Healthcare Management. “In 2022, I expect healthcare providers themselves will strengthen and formalize training to research and promote telehealth best practices to their clinicians. It’s already happening, and I expect to see specialties like mental health and urgent care shifting to a predominantly virtual model in 2022.”

Although the majority of the Forrester 2022 predictions are quite grim, one bright light is in the advancement of at-home services, particularly hospital-at-home services, and even the return of house calls. “The number of hospitals that deliver care at home will triple,” Forrester predicts. “The lessons learned by hospital facilities echoed the importance of surge planning along with a need for establishing a method of delivering acute care outside its walls.” 

Managed Healthcare Executive notes that integrating virtual healthcare with in-person care will be important. “In the future, the focus will shift to achieving optimal quality, appropriateness, experience and integration of virtual health with in-person delivery. There is a need for patient navigation across in-person and virtual care solutions, in such areas as clinical and data integration, and challenges with appropriate reimbursement; cost-sharing; and policy barriers. ” 

Trend 7: Healthcare organizations will still be looking for ways to improve operations and care while increasing efficiency and value. 

“In the wake of a pandemic that laid bare weaknesses of our current delivery system, I anticipate an accelerated uptake of tools and solutions designed to shorten the cycle between identification of clinical problems and implementation of clinical solutions based on evidence,” Savkar told Hospital and Healthcare Management

Burroughs writes in HealthTech that, “more organizations are deploying solutions that facilitate real-time access to patient information and seamless collaboration among care teams. The next step will be refining their features and workflow integrations, especially in ways that align with the unique requirements of specific teams and providers.” 

hc1 is also putting renewed focus on the powerful role operations management solutions play in delivering precision health. The coming year will see new enhancements for hc1 Analytics™ and hc1 Operations Management™, lab insights solutions which help healthcare organizations better serve their clinicians and patients by enabling quick access to the insights needed to improve how they manage internal and external processes and relationships. 

Trend 8: Patient mental health and emotional wellbeing will be a focus

In an April 2021, Morbidity and Mortality Weekly Report (MMWR) the CDC shared that “during August 19, 2020–February 1, 2021, the percentage of adults with symptoms of an anxiety or a depressive disorder during the past 7 days increased significantly (from 36.4% to 41.5%), as did the percentage reporting that they needed but did not receive mental health counseling or therapy during the past 4 weeks (from 9.2% to 11.7%). Increases were largest among adults aged 18–29 years and among those with less than a high school education.” 

While the pandemic has helped reduce stigma around seeking care for mental health and emotional well-being, it has also significantly increased the need for care. “Employers are providing access to mental health and emotional well-being through online resources and digital therapy, which can bridge access gaps for employees. Still, employers remain focused on the quality of these resources,” writes Managed Healthcare Executive

Trend 9: Precision Health will continue to grow. 

While precision health has already seen significant adoption in cancer care, current trends are pushing the precision health focus to all areas of care delivery. “Drug and diagnostic developers are now exploring precision approaches in other areas of medicine, including neuroscience, immunology and women’s health,” write Alessia Deglincerti  and Rachel Laing in Drug Target Review

Optimism about the potential for precision health balanced with a recognition of the remaining hurdles were key themes of the second Precision Health Virtual Summit, held Aug. 31 and Sept. 1, 2021, and hosted in partnership by hc1 and Becker’s Healthcare. “The thing we need to remember is that precision medicine is about the whole patient story. It’s not just about the gene and the specific treatment that’s been based on that gene,” said Gilan El Saadawi, MD, PhD, Founder and Chief Medical Officer, Realyze Intelligence, during her Summit presentation. “When we think of precision medicine we are proposing the customization of the care of the patient with the medical decisions, practices tailored to that and taking genomics into consideration.”

Trend 10: Healthcare tech will continue to explore Artificial Intelligence (AI) and digital healthcare modeling as healthcare providers begin to welcome it into their workflow. 

“When we think about artificial intelligence applied to populations, where my mind goes is how to become more preventative,” said hc1 chairman and CEO, Brad Bostic, in a discussion with Brian Patty, MD, CMIO, Medix Technology, during the Twenty-First Population Health Colloquium. “To the extent that we can zero in on these data sets like lab data and all of those diagnostic results and the related medications that are getting prescribed and really optimize that we see that as a great opportunity for artificial intelligence and machine learning.”

Hedges writes in Software Advice that small healthcare organizations take advantage of AI and Machine Learning today “by strategically investing in existing software systems that have already integrated this tech into their operating systems. Things like chatbots and intelligent decision support systems are already widely available.”

“If you think about the more tangible way to describe what AI can bring to bear is the digital twin,” said Bostic. “What we need to have is the computational model of every single individual patient that can be tested in a digital way before the actual human being receives the treatment or gets the kind of diagnostic that’s really invasive or has some kind of radical procedure. That digital twin necessitates artificial intelligence.” 

To learn more about hc1’s vision for the digital twin and the future of precision health, watch our Vision for Precision Health video.

By Lauren VanDenBoom
Share

November 30, 2021

Giving back to our wider community is something hc1 and our team is passionate about. This Giving Tuesday, we would like to share some of the ways that hc1 gives back and a list of our employees’ favorite charitable organizations in case you are looking for ways to contribute.  

This December, hc1 is participating in the Salvation Army’s Angel Tree Program. Employees have generously donated toys, clothes and other requested items to ensure our adopted “Angels” receive some needed and wanted gifts.

hc1 also chooses to give back as part of our corporate gifting during this time of year by  sharing Cookies for Kids Cancer with our clients.  Cookies for Kids Cancer is committed to raising funds for research to develop new, improved, and less toxic treatments for pediatric cancer — the #1 disease killer of children in the U.S. 

Our hc1 team has a varied list of interests and shared the below list of causes they like to support. Whether you are interested in supporting an organization monetarily or just through generating awareness, here are some suggestions. 

 Area of Interest  Organizations 
 Animals Best Friends Animal Sanctuary
Exotic Feline RescueOur Lil Bit of Heaven Animal Rescue and SanctuaryThe Humane SocietyWorld Wildlife Fund
 Children 

CHERISH Child Advocacy Center

Children International

Foundation for Grieving Children

Horizons at St. Richards Episcopal School

LeBron James Family Foundation

Make-a-Wish

Riley Hospital for Children

St. Jude Children’s Hospital

Team Impact

 Community

Good Samaritan Network

Habitat for Humanity

Keep Indianapolis Beautiful

Natural Resources Defense Council

 Health

Alzheimer’s Association

American Cancer Society

American Foundation for Suicide Prevention

Doctors without Borders

Rock Steady Boxing

Special Olympics

Susan G. Komen

 Homelessness

Back on My Feet

Wheeler Mission

 Human Rights

A21

Equal Justice Initiative 

 Hunger

Gleaners Food Bank

Broomfield FISH

Fueled for School

Meals on Wheels

Midwest Food Bank

Second Helpings 

St. Vincent de Paul Food Pantry

 Veterans

Disabled Veterans of America

The Wounded Warrior Project

By Lauren VanDenBoom
Share

October 21, 2021

How to best use technology for the advancement of healthcare is not a new pursuit. “As much as the last 10 years have been about the rollout of digitization of health records for the purposes of efficiency (and in some healthcare systems, billing/reimbursement), the next 10 years will be about the insight and value society can gain from these digital assets, and how these can be translated into driving better clinical outcomes with the assistance of AI, and the subsequent creation of novel data assets and tools,” writes Bajwa, Munir, Nori and Williams in Future Healthcare Journal

On October 14, 2021, hc1 chairman and CEO, Brad Bostic, and Brian Patty, MD, CMIO, Medix Technology, joined the Twenty-First Population Health Colloquium hosted by Thomas Jefferson University for a discussion on Optimizing Healthcare Data with Artificial Intelligence. During their discussion, Dr. Patty noted that while electronic health records vendors have improved interoperability and capabilities over the last few years, now data is coming to physicians from multiple sources in such significant quantities that they can’t keep up. 

“Gathering and making sense of this data then is very challenging,” said Dr. Patty. “A few years ago I talked to some physicians and they said, ‘I just don’t even look at it. I just look at what’s from my own EMR, because I don’t have time to collate all of this data.’ So that’s the big opportunity with AI and Machine Learning is to be able to take this data, collate it and make sense of it and deliver it into the workflow as actionable knowledge.“

Bajwa, et al. write “It is clear that we are at a turning point as it relates to the convergence of the practice of medicine and the application of technology, and although there are multiple opportunities, there are formidable challenges that need to be overcome as it relates to the real world and the scale of implementation of such innovation.” 

What do we mean by AI and ML? 

Artificial Intelligence (AI), “refers to the science and engineering of making intelligent machines, through algorithms or a set of rules, which the machine follows to mimic human cognitive functions, such as learning and problem solving,” write Bajwa, et al. “AI systems have the potential to anticipate problems or deal with issues as they come up and, as such, operate in an intentional, intelligent and adaptive manner. AI’s strength is in its ability to learn and recognize patterns and relationships from large multidimensional and multimodal datasets; for example, AI systems could translate a patient’s entire medical record into a single number that represents a likely diagnosis. Moreover, AI systems are dynamic and autonomous, learning and adapting as more data become available.”

Bajwa, et al. consider machine learning (ML) to be a subset of AI. They write it is “the study of algorithms that allow computer programs to automatically improve through experience.”

According to Dr. Patty, AI and ML are particularly suited for pattern recognition, which enables us “to set these systems up in the background to be able to consume all this data, look for patterns in the data, and look for either warning signs for somebody who’s in the rising risk category who needs more attention clinically or just seeing a diagnosis that may have been missed.”

In the case of many disease states like cirrhosis, chronic kidney disease, and many others, there are subtle signals in the diagnostic lab data that may be missed if a physician isn’t looking at all of the data points together. “When we think about artificial intelligence applied to populations, where my mind goes is how to become more preventative,” said Mr. Bostic. “To the extent that we can zero in on these data sets like lab data and all of those diagnostic results and the related medications that are getting prescribed and really optimize that we see that as a great opportunity for artificial intelligence and machine learning.”

Bajwa, et al. write that “AI can enable healthcare systems to achieve their ‘quadruple aim’ by democratizing and standardizing a future of connected and AI-augmented care, precision diagnostics, precision therapeutics and, ultimately, precision medicine. Research in the application of AI healthcare continues to accelerate rapidly, with potential use cases being demonstrated across the healthcare sector (both physical and mental health) including drug discovery, virtual clinical consultation, disease diagnosis, prognosis, medication management, and health monitoring.”

How can we practically apply AI in healthcare?

Precision population health is “about driving the kinds of signals all the way to the clinical caregivers in such a way that they can avoid inappropriate testing, missed tests or therapy that’s not going to work upstream,” said Mr. Bostic. 

Dr. Patty said that healthcare only impacts maybe 10 percent of a person’s health. Other factors like genetics, lifestyle, and socioeconomics have a greater share of the impact. Those factors are something a frontline provider is not really able to collate and deal with. AI and ML, however, are perfect for the challenge. 

“If you think about the more tangible way to describe what AI can bring to bear is the digital twin,” said Mr. Bostic. “What we need to have is the computational model of every single individual patient that can be tested in a digital way before the actual human being receives the treatment or gets the kind of diagnostic that’s really invasive or has some kind of radical procedure. That digital twin necessitates artificial intelligence.” 

Taking a practical look at what is possible today, Mr. Bostic said, “What we’ve seen with the here and now is there is no more scalable data set to help inform more precise, optimized healthcare than diagnostic lab data. Whether you’re sick, healthy, or somewhere in between, you end up having lab tests run and that generates all kinds of information that can be leveraged to be more precise and create an optimal approach to how you’re diagnosed in a more preventative, proactive approach. To do that requires a level of machine learning to marry up all these different lab data sets that get generated by different labs that happen within different clinical settings with different providers to create more of that overall health matrix and sort of the beginnings of that digital twin all made up of this initial lab data set.” 

He said this approach can be used to address the use of testing to ensure it is appropriate, both reducing wasteful testing and ensuring testing is not underutilized creating under-identification of those at risk. “The lab data set and having the right kind of partnership to power insights using AI and Machine learning at that level is an excellent practical start,” he said. “And then the second part of that is what do you do once you know the diagnosis you aim to get the right treatment. These are all things that by doing them you can make people much  healthier and you can make it so that you’re creating the future of healthcare we all want which is oriented around a much better outcome.”

What to know more about how hc1 is impacting the future of precision health? Click here to watch Our Vision for Precision Health video.

By Heather Stith
Share

October 1, 2021

Even though all humans are 99.9% the same at the genetic level, there are billions of DNA base-pair differences among individual humans at the genomic level. Even identical twins can develop genomic differences in utero when DNA is being copied. Biological parents pass on their genes to their children, but those children can introduce dozens of mutations to their genetic inheritance. Additional differences at the epigenetic and epigenomic levels affect how genes will work in a specific person depending on behavior and environment.

All of these differences lay the groundwork for precision health. Precision health aims to not only use knowledge of a patient’s unique combination of biology, environment, and behavior to more effectively treat or even cure existing disease, but also to prevent disease and optimize wellness by pinpointing individual health risks.

Yet the path to precision health is not a straight line—it’s a loop with many stops along the way.  If we want this loop to become a virtuous cycle, patients must be centered at every point in the process.  The recent 2021 Precision Health Virtual Summit hosted by hc1 and Becker’s Healthcare explored how precision health is pushing different areas of healthcare to work together in new ways to improve patient outcomes.

Precision population health

At the surface, precision medicine’s focus on an individual patient’s genomics, behavior, and environment would seem to be at odds with population health’s focus on public health, health policy, economics, quality and safety, and data analytics. But in a keynote presentation at the 2021 Precision Health Summit, Dr. David B. Nash explained that these healthcare disciplines are complementary and can work together to better assess patients’ healthcare risks and deliver treatment efficiently and effectively.

A key concept from population health that can be used in the assessment of an individual’s health risk is the idea of social determinants of healthwhich are environmental factors such as food and housing insecurity and institutional racism that affect a patient’s quality of life and health outcomes.

Another population health concept that precision health initiatives will need to adopt to be successful is the importance of building trust within the patient community. Many populations have historical reasons for mistrusting medical institutions, so patient education, engagement, and outreach must happen before individual testing or treatment can occur. Dr. Nash stated the need for ongoing public accountability and transparency at the government level to regain and maintain the public’s trust.

Dr. Nash also spoke of three factors affecting the progress of precision health.

  • Culture of science: Scientists are continually testing and retesting and refining their thinking based on new evidence, but patients and the public at large are looking for clarity and certainty.
  • Economics: Precision health-related technology, such as PCR testing, has advanced quickly, but health care payment structures have not kept up to make the latest technology accessible on a wide scale.
  • Culture of clinical practice: Clinicians are trained to treat patients with “tried and true” methods, and care delivery systems are not set up to quickly and easily incorporate new  technologies and research.

Dr. Nash highlighted the new term that captures the central focus of his keynote address. When the elements of precision health for enhancing the care outcomes of each patient are merged with broad-based, community-focused initiatives critical to population health, he coined that comprehensive approach as “precision population health.”

Evidence-generating medicine

Increasingly, health researchers are using data collected during patient care as their evidence for studies. Dr. Umberto Tachinardi, Chief Information Officer of the Regenstrief Institute, highlighted hurdles researchers face when using this real-world data:

  • The data is messy and incomplete because it was collected for treatment purposes, not research.
  • Patient privacy must be protected, and potential patient identifiers are in multiple locations, increasing the difficulty of de-identifying data.
  • The computing involved in this type of research requires complex infrastructure and large datasets pulled from multiple sources to accurately train machine learning models.

To address these issues, Dr. Peter Embí, President and CEO of the Regenstrief Institute, said that we need to change the traditional idea of the one-way relationship between healthcare research and the practice of medicine. Clinical decisions should continue to be based on evidence from research and the patient’s circumstances and wishes, but the information about those decisions and their outcomes should also be fed back into research to create a learning health system. We need to move from evidence-based medicine to evidence-generating medicine.

Human-centered design

Even with all the amazing advances in precision medicine, Dr. Gilan El Saadawi pointed out in her breakout session that “the molecular diagnosis does not define a patient.” There are other important pieces of both structured and unstructured data needed to put together the whole patient story, and one technology or solution isn’t going to provide all the answers. Certainly not EMRs, which have been optimized for billing purposes, not for error reduction or ease of use.

“We can put all the technology magic in the world out there, but if humans aren’t engaging, that’s the biggest impediment that there is,” hc1 CEO Brad Bostic said during his fireside chat. Bostic emphasized that healthcare systems need to work for both patients and clinicians.

During the Chief Medical Information Officer (CMIO) panel, Dr. Albert  Villarin described Nuvance Health’s approach to human-centered design. They first collect a variety of patient data from lab testing and input from health devices, glucose monitors, for example. That data is then filtered through evidence sets such as patient registries for diabetes and high blood pressure. The last step is to notify both clinicians and patients of actions, such as screenings or check-ups, they may need to take because of health risks. He spoke about the challenges involved in putting the massive amount of collected healthcare information to good use. “It’s coming in as data, but going out as knowledge. That knowledge over time creates the wisdom around the one patient we’re taking care of.”

The path to precision health for all patients is not straightforward. What is clear is that progress will require communication, innovation, and collaboration from all parts of the healthcare ecosystem. 

Watch the full presentations from the  2021 Precision Health Virtual Summit here.

By Lauren VanDenBoom
Share

September 27, 2019

First, there was the hc1 mobile experience. With just a smartphone and Internet access, you could log into the hc1 URL and find what you need. A mobile-friendly website was a nice shortcut – a handy device for field access. Now we’ve created something better.

Introducing the hc1 iOS Mobile App 

We’ve developed an app that’s available for any current iOS smartphone. With a quick download, you can employ the power of your data through a user-friendly app. 

This new offering has the simple, clean look and responsive feel you’d expect from a well-designed mobile app. Large icons and collapsible menus that are easy-to-read make this an intuitive experience and invaluable tool. 

It’ll make your mobile log-in experience easier, and access remains at your fingertips.

The beta version of the hc1 mobile app will be available for any iOS smartphone beginning in January 2020. 

Check us out and discover all the ways hc1 can help improve lives with high-value care. 

By Lauren VanDenBoom
Share

October 22, 2019

On October 17, during the Day of Innovation at Butler University, hc1 Test Utilization™ received an Indiana Innovation Award. The award, presented by Centric®, recognizes individuals and organizations successfully leading the innovation charge in Indiana. To be eligible, the innovation must have been introduced within the last three years and be based in Indiana.

The judging committee considers four criteria:

  • Did the product/service meet an unmet need?
  • How unique is the product/service? Is this the first of its kind? If not, how is it different or better than existing products/services?
  • What new value has been created for the end-user?
  • What financial evidence or market acceptance information does the product/service have to support it? What is its quantifiable evidence of success?

Since its launch in 2017, hc1 Test Utilization™ has impacted millions of patient lives by transforming lab data into personalized healthcare insights. Across thousands of locations, customers are using Test Utilization to monitor ordering trends and gain insights into where testing can be optimized, ensuring patients get the right test at the right time.

“hc1 is proud to accept this Indiana Innovation Award,” said Brad Bostic, chairman and CEO of hc1. “Every year, an estimated $200 billion is wasted on excessive lab testing and associated treatments, resulting in added costs and risk to patients. With hc1 Test Utilization we set out to change that dynamic.”

A comprehensive solution, Test Utilization includes both strategic guidance and cloud-based technology. With it, healthcare teams have a dashboard of real-time lab data from in-hospital, outpatient and reference labs. By taking the guesswork out of launching an effective utilization program and proactively uncovering where unnecessary tests are being ordered, a health system can effectively monitor, take action and educate its physicians – all while creating a high-value, lean organization.

Test Utilization is part of hc1 High-Value Care Platform™, which eliminates waste and personalizes care for health systems and diagnostic laboratories nationwide by turning previously static lab data into actionable healthcare insights. At hc1.com read more about or request a demo of hc1 Test Utilization and other hc1 products that help health systems improve clinical outcomes and reduce medical spending.

By Lauren VanDenBoom
Share

June 24, 2019

Healthcare used to operate almost exclusively on a fee-for-service basis, meaning each service performed was a line item billed separately and regardless of the outcome. That era is passing. Increasingly, high-value care (HVC) is the new driving force. This trend toward a team-provided and patient-centered healthcare model impacts both physical and financial outcomes.

By Lauren VanDenBoom
Share

February 19, 2020

During a recent webinar, hc1 Director of Client Enablement, Maura Lee, gave a guided tour of hc1’s
latest new tool, the hc1 CRM™ app.

The iOS app puts the most highly used CRM sales features right at the user’s fingertips. From the app’s
eight main tiles users can quickly navigate to key record types and app features to view, create, and edit
hc1 CRM organization, contact, opportunity, case, task, and memo information.

To download the app, visit the iOS App Store and search for “hc1 CRM.”

Lee told webinar attendees they can maximize their efficiency with the app by 1) intuitively accessing all
key record types with a tap of a finger, 2) using quick action buttons to open a map or start an email or
phone call and use voice to text, 3) efficiently logging interactions with clients and review past
interactions, 4) quickly viewing critical information and access additional data in collapsible menus, and
5) using streamlined search capability to find clients and contacts.

If you missed the webinar it’s not too late to learn more about navigating and using the new hc1 CRM
app. Visit our CRM solutions page for more information about the app.

By Lauren VanDenBoom
Share

February 12, 2020

hc1 has announced a new iOS app companion for its popular hc1 Healthcare CRM™ solution. hc1 CRM users can now access the most highly used CRM sales features right from their iOS devices. 

hc1 Healthcare CRM™ streamlines communication and data sharing from sales activities to client and patient relationships to operations initiatives. Leaders use the highly customizable solution to seamlessly integrate, analyze, and visualize organizational metrics to quickly see value, track trends in real-time, and gain insights into relationships. 

Now with the hc1 CRM™ app, users can view, create, and edit hc1 CRM organization, contact, opportunity, case, task, and memo information with they are away from their desks. They can quickly review client activities before walking in the door, map the location for their next visit, or find contact information and initiate a call or email with just a screen tap. 

“The new app is intuitive and streamlined,” commented one user during the app’s testing period. “No noise –  just what our sales team needs to efficiently log interactions with clients and review past interactions on the go.”

hc1 CRM users can visit the iOS App Store to download and begin using the app today. To learn more, visit our CRM web page and join us for an upcoming webinar where we will discuss navigation of the app, multiple ways the app can make your sales process more efficient, and a live Q&A to answer your questions. 

By Lauren VanDenBoom
Share

August 23, 2021

“I’ve been often asked the question about personalized medicine and the practical nature of that, and, ultimately, will it ever be mainstream?” hc1 Chairman and CEO, Brad Bostic, recently told MarketScale. “My point of view on that is absolutely it will be. What I see happening right now within health care is this Renaissance that gives us a chance at getting there sooner rather than later.”

On August 31 and September 1, attendees at the 2021 Precision Health Virtual Summit hosted by hc1 and Becker’s Healthcare will learn what the future of precision health looks like, but also how that future is achievable today. 

Precision health has huge potential to impact and achieve all four arms of healthcare’s quadruple aim to:

  1. improve population health, 
  2. improve the patient’s experience of care, 
  3. enhance caregiver experience and 
  4. reduce the rising cost of care.

Those who join us will have an opportunity to hear from some of our nation’s most renowned thought leaders on precision health, precision prescribing, precision diagnostics, population health and on just how technology is coming together with precision health practices to achieve healthcare’s aims. 

Fireside chats to open the discussion 

Each day of the Summit will open with a forward looking fireside chat. On the first day, Purdue University President, Cerner Corporation board member and former Indiana Governor, Mitch Daniels, and hc1 CEO, Brad Bostic, will discuss the importance of precision health to our healthcare system and how implementing precision health practices is possible and practical today. On the second day, Jeffrey Kuhlman, MD, General Manager, Healthcare Analytics Solution AdventHealth, will discuss how precision health and genomics are unlocking individuality. 

Keynote thought leadership

During a keynote discussion with David B. Nash, MD, MBA, Founding Dean Emeritus, Jefferson College of Population Health, and Scott Becker, Publisher and Founder of Becker’s Healthcare, you’ll hear Dr. Nash’s perspectives on how precision health and population health are tightly related. He will explain how eliminating waste in population health is a driver for precision health and how this ties into addressing cost and access concerns in delivering individualized care for all patients.

In her keynote presentation, Katherine Capps, President, Health2 Resources; Co-Founder & Executive Director, GTMRx Institute, and Jennifer Hockings, Pharmacogenomics Clinical Specialist at Cleveland Clinic, will discuss the future of precision health. Ms. Capps has a long history of collaboration in multi-stakeholder environments and has led the growth of GTMRx—an organization focused on cross-collaboration to advance appropriate use of medications and gene therapies—to over 1,200 members from 800 companies in less than two years. A gifted communicator, she cultivates and manages relationships with stakeholders across the health care and health policy spectrums.

Thought provoking panel discussions

The Summit will feature three panel discussions focused in areas where precision health practices are being implemented and will show benefit. 

The precision prescribing-focused panel will discuss the lab’s critical role in precision health and how to ensure clinicians are best equipped for decision-making. Attendees will hear their insights on how precision health insights can be injected into the workflow, without added burden to the physician.The panel will be moderated by Robert Michel, Editor-in-Chief, DARK Daily and The Dark Report, and will include Matthew Katz, Principal, MCK Health Strategies, LLC; Kristine Ashcraft, Medical Director for Pharmacogenomics, Invitae; Yuri Fesko, MD, Executive Medical Director of Medical Affairs, Quest Diagnostics; and Jordan Olson, MD, Division Chief, Clinical Pathology Informatics and Quality at Geisinger. 

Leading a panel of Chief Medical Information Officers (CMIOs) will be Brian D. Patty, MD, CHCIO, CMIO of Medix Technology. They will discuss the broader implications of precision health, as well as share their thoughts on actioning data and gaining physician adoption by delivering insights at the right time, in the right way, without interrupting workflow. As the bridge between the IT and clinical worlds, they will discuss challenges, successes and what the future holds. Albert Villarin, MD, FACEP, Vice President and CMIO, Nuvance Health, and Stephanie Lahr, MD, CHCIO, CIO and CMIO, Monument Health, will participate in the discussion. 

On the second day of the Summit, a panel of pharmacists and healthcare strategists moderated by Behnaz Sarrami, MS, PharmD, Medical Science Liaison, AltheaDx, will discuss connecting pharmacists and providers for a team-based approach to delivering precision health care. They will explore how physician practices can use lab and pharmacy data to better coordinate care for their patients, as well as demonstrate clinical utility and actionability to ensure payment.

Special Guest Speakers 

Several notable special guests will also join this year’s agenda to discuss both forward looking and current applications of precision health. 

The difference between a traditional assessment of a complex patient condition and true “precision medicine” is the degree of reliance on available data – at point of care – to make decisions about specific treatment paths that may be more beneficial for the patient. Gilan El Saadawi, MD, PhD, MS, Chief Medical Officer, Realyze Intelligence, will present how to achieve a path to true personalized healthcare we need to step back from locking data in disparate silos (genomic, EMR, claims, etc.) and start thinking of building a patient model that reflects the whole patient story with all these pieces fitting together and allowing patterns to emerge from this picture.

Rehan Waheed, MD, Senior Medical Director & CMIO Healthcare Analytics Solutions, Quest Diagnostics, will discuss how when the right care is provided to individual patients at the right time using the right tests, a massive amount of data is collected from these new discoveries and insights. His discussion will highlight the importance of leveraging trends gained from individual data and research to affect population health by creating more opportunities for impactful patient interventions, powering better outcomes for all.

Joining from Regenstrief Institute, Peter Embi, MD, MS, FACP, FACMI, FAMIA, FIAHSI, President & CEO, and Umberto Tachinardi, MD, MS, FACMI, IAHSI, CIO, will share emerging ideas on infrastructure and ethical considerations for advancing real world data and evidence in health. 

Todd Crosslin, Global Head of Healthcare and Life Sciences with Summit sponsor, Snowflake, will introduce the Data Cloud and its relevance to Healthcare. He will then take participants through a live tour of the Data Marketplace to see how organizations can connect to data without copy, FTP, or API to find new insights and/or enhance their machine learning models with data sources such as social determinants of health, adverse events, and COVID.

Anthony Morreale, PharmD, MBA, BCPS, FASHP, Associate Chief Consultant for Clinical Pharmacy Services and Policy, US Department of Veterans Affairs, an experienced senior clinical pharmacy leader, will share how to identify gaps in healthcare initiatives and implement changes in a rapidly growing healthcare system. He will also discuss the challenges of scaling up a clinical pharmacy workforce to keep up with technology.

Added Remarks

Rounding out the first day will be opening remarks from Brad Bostic, Chairman and CEO, hc1, and closing remarks from Molly Gamble, Vice President of Editorial, Becker’s Healthcare. Mike Lukas, Vice President and General Manager, Health Systems, Quest Diagnostics, will open the Summit’s second day and Mr. Bostic will offer his final closing remarks at the end of the second day. 

hc1, Becker’s Healthcare, and Summit sponsors Quest Diagnostics, AWS and Snowflake, are excited to welcome more than 2,000 registered attendees to this important event for precision health. If you have not yet registered there is still plenty of time to do so at www.hc1.com/Summit where you can also find the complete agenda and more information about our speaker and sponsors. If you are still wondering why you should attend, check out my recent blog post on the top five reasons

When attending the Summit, if you have a question that is not answered during the presentation or you think of one after the fact, I’d be happy to pass that along for you. Just send me your message at https://www.hc1.com/summit/contact-us.